Literature DB >> 25372438

Acute exudative polymorphous vitelliform maculopathy in a young man: a case report.

Kunjal K Modi1, Daniel B Roth, Stuart N Green.   

Abstract

PURPOSE: To describe ocular findings consistent with acute exudative polymorphous vitelliform maculopathy in a healthy 34-year-old man.
METHODS: Observational case report of a patient presenting with blurred vision in the left eye greater than the right eye.
RESULTS: Funduscopic examination and fluorescein angiography were consistent with acute exudative vitelliform maculopathy, a rare exudative macular disorder. Five months after presentation, the patient was diagnosed with metastatic melanoma.
CONCLUSION: A case is reported in a young man with no diagnosis of primary neoplasm at the time of presentation, and no other symptoms overall, who was later diagnosed with a metastatic malignancy.

Entities:  

Mesh:

Year:  2014        PMID: 25372438     DOI: 10.1097/ICB.0000000000000042

Source DB:  PubMed          Journal:  Retin Cases Brief Rep        ISSN: 1935-1089


  4 in total

1.  [Paraneoplastic serous retinopathies: hormones, mediators, and inhibitors].

Authors:  R S Grajewski; L M Heindl
Journal:  Ophthalmologe       Date:  2017-04       Impact factor: 1.059

2.  Paraneoplastic acute exudative polymorphous vitelliform maculopathy improved with intravitreal methotrexate.

Authors:  Jie Gao; Ketaki Panse; C Stephen Foster; Stephen D Anesi
Journal:  Am J Ophthalmol Case Rep       Date:  2020-09-16

3.  Nonantibestrophin Anti-RPE Antibodies in Paraneoplastic Exudative Polymorphous Vitelliform Maculopathy.

Authors:  Lauren A Dalvin; Adiv A Johnson; Jose S Pulido; Ranjit Dhaliwal; Alan D Marmorstein
Journal:  Transl Vis Sci Technol       Date:  2015-05-15       Impact factor: 3.283

4.  Exudative Polymorphous Vitelliform Retinopathy: Importance of Early Recognition of the Condition in Patients with Metastatic Melanoma.

Authors:  Norah Lincoff; Muhammad Nadeem; Zilfah Younus; Charles E Thirkill
Journal:  Ophthalmol Ther       Date:  2016-02-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.